Company News in the Life Science Industry

»

Reset 

$6.5 billion in NIH funding for foundational research enabled Emergency Use Authorization of remdesivir for treating COVID-19

WALTHAM, Mass., July 7, 2020 /PRNewswire/ -- The unprecedented emergency authorization of remdesivir for treating COVID-19 only four months after the virus was discovered was enabled by decades of basic research on the drug's biological target and drugs with similar parent structures, and was... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020
Related companies:  Bentley University

LI-COR Near-Infrared Assays and Technology Offer Insight to Coronavirus Researchers

LINCOLN, Neb., July 7, 2020 /PRNewswire/ -- The SARS-CoV-2 coronavirus and subsequent COVID-19 pandemic places the subject of viruses and virology in the research spotlight for good reason. Scientists are seeking to understand the virus, characterize infectivity, and understand its mechanism... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020
Related companies:  LI-COR Biosciences

Kugler Vision Rolls Out New, Innovative LASIK Consultation Experience for 2020

OMAHA, Neb., July 7, 2020 /PRNewswire/ -- At Kugler Vision,... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020

Cure SMA Urges Remaining States to Expedite Adoption of Newborn Screening for Spinal Muscular Atrophy

CHICAGO, July 7, 2020 /PRNewswire/ -- Cure SMA released a new report card highlighting that two-thirds of states have implemented screening for spinal muscular atrophy (SMA) as part of their Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020
Related companies:  CURE SMA

How Redefining Travel in a COVID-19 World Can Impact Mental Health, Human Connection and More

NEW YORK, July 7, 2020 /PRNewswire/ -- Adventure Explorations presents a newly released white paper entitled "The Future Is Now." The piece takes a closer look at what life looks like in a COVID-19 world and how mental health, travel and communing with nature are being redefined.

Read more ››
By: PR Newswire Association LLC. - 07 Jul 2020

BioLife Solutions Announces Closing of $86 Million Public Offering of Common Stock

BOTHELL, Wash., July 7, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"),... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020
Related companies:  BioLife Solutions, Inc.

Frontage expands synthetic & medicinal chemistry and process research & development services by acquisition of ACME Bioscience

EXTON, Penn., July 7, 2020 /PRNewswire/ -- Frontage Holdings Corporation ( "Frontage" or the "Group", 1521.HK), a contract research organization ("CRO") providing integrated, science-driven research and development services with presence in both North America and China, today announced Frontage... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020
Related companies:  Frontage Laboratories, Inc.

Dramatic Health Introduces Game Changers in Medicine Podcast Series

NEW YORK, July 7, 2020 /PRNewswire/ -- Game Changers in Medicine, the new monthly podcast from Dramatic Health, premieres on July 8, 2020, with "Vitamin K: This vitamin you've never heard of may have saved your life," episode one of a planned six-part series about the serendipitous events,... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020

UCB and Ferring Pharmaceuticals Announce Co-Promotion of CIMZIA® (certolizumab pegol) for the Treatment of Adults with Moderate to Severe Crohn's Disease

ATLANTA and PARSIPPANY, N.J., July 7, 2020 /PRNewswire/ -- UCB and Ferring Pharmaceuticals Inc. today announced they have entered into a co-promotion agreement to commercialize the prefilled syringe formulation of CIMZIA(®) (certolizumab pegol) in the United States, specifically for the treatment... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020
Related companies:  UCB INC. (US)

Biotech Startup Announces R&D Collaboration With Major Japanese Drug Delivery Company

SAN CARLOS, Calif., July 7, 2020 /PRNewswire/ -- CAGE Bio Inc. today announced a research and development agreement with Nitto Denko Corporation for a transdermal formulation of undisclosed molecules. The goal of the partnership is to explore the potential for developing therapeutic products... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020
Related companies:  Nitto Denko Technical Corporation | Nitto Denko Avecia Inc.

FDA Grants Soterix Medical IDE Approval for Home-based tDCS-LTE Trial for Depression

NEW YORK, July 7, 2020 /PRNewswire/ -- Soterix Medical Inc. announces it has received FDA Investigational Device Exception... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020
Related companies:  Soterix Medical Inc.

Top US Scientists First To Report Data On New Biodefense Technology Proven To Eliminate Airborne Transmission Of SARS-CoV-2 To Control Spread Of COVID-19 Indoors

HOUSTON, July 7, 2020 /PRNewswire/ -- As evidence showing a real risk of airborne transmission of SARS-CoV-2 (Coronavirus responsible for COVID-19) continues to mount, Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020

ValueHealth and ChristianaCare Announce High-Performance Surgical Joint Venture in Delaware, Maryland, Pennsylvania and New Jersey

WILMINGTON, Del., July 7, 2020 /PRNewswire/ -- ChristianaCare, one of the most dynamic health systems in the Mid-Atlantic Region, and ValueHealth, LLC, a nationally recognized tech-enabled surgical platform company, have entered into a joint venture partnership that will advance value-based care... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020

Open Source Imaging Consortium (OSIC) Launches $55,000 AI Competition to Help Pulmonary Fibrosis Patients

HOLLAND, Mich., July 7, 2020 /PRNewswire/ -- The Open Source Imaging Consortium (OSIC) announced today the launch... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020

Pressure BioSciences First Quarter 2020 Financial and Business Update to Include Jim Morrison, In-Coming CEO for Merged Companies of Availa Bio

SOUTH EASTON, Massachusetts, July 7, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its First Quarter 2020 financial results and to provide a business update, including discussions... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020
Related companies:  Pressure BioSciences, Inc

Global Fall Protection Equipment in Rescue Market (2019 to 2024) - Trends, Forecast, and Competitive Analysis

DUBLIN, July 7, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020

Published Research Assesses Impact of Health Union's Online Health Community Model

PHILADELPHIA, July 7, 2020 /PRNewswire/ -- Research from Health Union that further validates the benefits of its online community model for people living with chronic health concerns has been published in the July 2020 issue of the peer-reviewed Journal of Medical Internet Research. The paper,... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020

New Study Shows That Hydroxychloroquine Saves Lives, States Association of American Physicians & Surgeons (AAPS)

TUCSON, Ariz., July 7, 2020 /PRNewswire/ -- A just published peer-reviewed... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020

TALLC Corporation Announces Grant of New SmartCelle Patent for Enhanced Ocular Delivery of TA-A001

MONTREAL, July 7, 2020 /PRNewswire/ -- TALLC Corporation Inc. (TALLC) a pioneering pharmaceutical company using proprietary new molecular entities to treat acute and chronic inflammation today announced that the United Kingdom Intellectual Property Office (IPO) has granted TALLC... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020

InMed Announces Dosing Initiation in 2nd Phase 1 trial with INM-755

TSX:IN
OTCQX:IMLFF

Read more ››
By: PR Newswire Association LLC. - 07 Jul 2020
Related companies:  InMed Pharmaceuticals Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 21  22  23  24  25 »

Explore our database of over 50,000 companies